Shionogi & Co., Ltd.
Research Shionogi & Co., Ltd. (4507.T) on Bullrun: market cap JPY 2.50T, P/E 9.5, dividend yield 2.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4507.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyJPY
- Market capJPY 2.50T
- P/E9.5
- Dividend yield2.6%
- Financial periodFY2026
- RevenueJPY 499.68B
- Revenue growth14.0%
- Net incomeJPY 205.16B
- Free cash flowJPY 182.27B
- Gross margin83.5%
Valuation Snapshot
latest market cap is JPY 2.50T; P/E is 9.5; dividend yield is 2.6%.
Peer valuation comparison
Latest P/E is 9.48x versus a Healthcare sector median of 21.69x (56.3% below).
Latest dividend yield is 2.55% versus a Healthcare sector median of 2.41% (5.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 499.68B | JPY 205.16B | JPY 182.27B | 83.5% | 241.04 | JPY 711.40B | JPY 684.39B | JPY 1.69T |
| FY2025 | JPY 438.27B | JPY 170.44B | JPY 143.36B | 85.4% | n/a | JPY 374.80B | JPY 21.88B | JPY 1.36T |
| FY2024 | JPY 435.08B | JPY 162.03B | JPY 126.02B | 86.8% | 186.11 | JPY 358.09B | JPY 11.62B | JPY 1.24T |
| FY2023 | JPY 426.68B | JPY 184.97B | JPY 140.68B | 85.4% | 207.03 | JPY 309.22B | JPY 9.41B | JPY 1.10T |
| FY2022 | n/a | n/a | n/a | n/a | 126.21 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 2.50T | 9.5 | 2.6% | 76 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 76 JPY, yield 2.6%.
| Year | Dividends/share |
|---|---|
| FY2026 | 76 JPY |
| FY2025 | 66 JPY |
| FY2024 | 56.67 JPY |
| FY2023 | 50 JPY |
| FY2022 | 40 JPY |
About Shionogi & Co., Ltd.
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Shionogi & Co., Ltd.'s market cap?
Shionogi & Co., Ltd.'s market capitalization is JPY 2.50T.
What is Shionogi & Co., Ltd.'s P/E ratio?
Shionogi & Co., Ltd.'s price-to-earnings (P/E) ratio is 9.5.
Does Shionogi & Co., Ltd. pay a dividend?
Shionogi & Co., Ltd. has a dividend yield of 2.6%.
What does Shionogi & Co., Ltd. do?
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.